NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”), of the important January 26, 2026 lead plaintiff deadline.

Wedbush analysts said recent changes at Meta Platforms Inc (NASDAQ:META, XETRA:FB2A, SIX:FB) reflect a more disciplined and intentional investment approach, even as the company continues to spend heavily on artificial intelligence and hardware initiatives. The assessment follows a series of reports pointing to job cuts and a reallocation of resources within Meta's Reality Labs unit as the company refocuses on consumer hardware and wearables.

Meta cuts over 1,000 jobs from its Reality Labs division as the company shifts its focus from metaverse products to wearable technology investments and development.

Crinetics Pharmaceuticals, Inc. (CRNX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Charles River Laboratories International, Inc. (CRL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Enterprise Products Partners remains a "Buy," offering a compelling risk/reward profile and a nearly 7% yield amid sector underperformance. EPD's Q3 showed mixed results: revenue beat but EBITDA and EPS missed, with management cautious on near-term growth due to project delays. Despite recent earnings downgrades, EPD's disciplined capital returns, strong balance sheet, and $5 billion buyback program support valuation upside.

KLAR ALERT: Klarna Group plc Sued For Securities Fraud; Investors Who Lost Money Should Contact Block & Leviton to Potentially Recover Losses Boston, Massachusetts--(Newsfile Corp. - January 13, 2026) - Block & Leviton announces that a securities fraud lawsuit has been filed against Klarna Group plc (NYSE: KLAR) and certain of its executives. Investors who have lost money in their Klarna Group investment should contact the firm to learn more about how they might recover those losses.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC (“Klarna” or the “Company”) (NYSE: KLAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Affirm Holdings remains the leading U.S. BNPL platform, with strong execution, resilient credit metrics, and a multi-year growth runway. AFRM's upcoming quarter, covering the robust holiday shopping period, is expected to showcase continued strength as consumer adoption of BNPL accelerates. Potential credit card interest rate caps could structurally benefit BNPL providers like AFRM, driving further market share gains among underbanked consumers.

Equity Residential trades near its 52-week low, offering a 4.6% yield and a forward P/FFO of 15.1, well below its historical average. EQR benefits from record tenant retention, strong occupancy, and minimal new supply in key coastal markets, supporting pricing power. AI-driven efficiencies are reducing application times and operating costs, positioning EQR for improved margins and tenant experience in 2026 and beyond.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. (“Apogee” or the “Company”) (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. (“AST” or the “Company”) (NASDAQ: ASTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Netflix is working on revised terms for its Warner Bros Discovery acquisition and has discussed making its offer all cash for the purchase of the company's studios and streaming businesses, Bloomberg News reported on Tuesday.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. (“Quantum” or the “Company”) (NASDAQ: QNTM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.